# Autologous Cell Therapy for Female Stress Urinary Incontinence

> **NCT01008943** · PHASE2 · COMPLETED · sponsor: **Cook MyoSite** · enrollment: 16 (actual)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **BIOLOGICAL:** Autologous Muscle Derived Cells

## Key facts

- **NCT ID:** NCT01008943
- **Lead sponsor:** Cook MyoSite
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-02
- **Primary completion:** 2012-09-21
- **Final completion:** 2012-09-21
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01008943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01008943, "Autologous Cell Therapy for Female Stress Urinary Incontinence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01008943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*